Alnylam Pharmaceuticals reported $2.69B in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Amgen AMGN:US USD 22.19B 1.88B
Arrowhead Research ARWR:US USD 405.3M 27.09M
Avrobio Inc AVRO:US USD 126.23M 15.85M
Biomarin Pharmaceutical BMRN:US USD 2.68B 165.1M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Moderna Inc MRNA:US USD 14.3B 734M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NVS:US USD 36.91B 44M
Ptc Therapeutics PTCT:US USD 517.26M 177.41M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Regulus Therapeutics RGLS:US USD 49.37M 2.02M
Sangamo Biosciences SGMO:US USD 336.62M 6.5M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Takeda 4502:JP JPY 2.6T 149.67B
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
Xencor XNCR:US USD 668M 82.06M
YTE INCY:US USD 3.82B 195.27M